Overview of the testing strategy stages that the Japanese Red Cross has gone through (HBV, HIV)
|
|
- Christal Melton
- 5 years ago
- Views:
Transcription
1 2014/LSIF/PD/006 Overview of the Testing Strategy Stages That the Japanese Red Cross (JRC) Has Gone Through (HBV, HIV) - The JRC Approach to Donor Recruitment in the Era of Aging Population Submitted by: Japanese Red Cross (JRC) Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply Chain Manila, Philippines 30 September 1 October 2014
2 Overview of the testing strategy stages that the Japanese Red Cross has gone through (HBV, HIV) The JRC approach to donor recruitment in the era of aging population Masahiro Satake Japanese Red Cross Headquarters Central Blood Institute
3 Transfusion-transmitted HBV infection Risk-harboring population Donors in Window Period Sensitive NAT Donors with occult HBV infection (OBI) (HBsAg-negative but HBV DNA-positive, usually anti- HBc-positive) Highly sensitive NAT Rejection of anti-hbc-positive donors
4 Development of screening strategies for HBV Serology 1972 HBsAg (agglutination method) 1989 Anti-HBc/anti-HBs Anti-HBc cutoff.. x years sample storage NAT 1997 Anti-HBc cutoff.. x p-NAT (HBV, HCV, HIV) p-NAT p-NAT 2008 ŐŐůƵƟŶĂƟŽŶї >/ p-NAT (sample vol. x3) 2012 Entire anti-hbc-positives rejected 2014 ID-NAT
5 Anti-HBc/anti-HBs combination assay for HBsAg-negative blood Anti-HBc 12.9 % among first time donors in 1980s Anti-HBc titer Low < 2 6 (2 5 ) or 1.0 S/CO < 12.0 High 2 6 (2 5 ) or S/CO 12.0 Anti-HBs 200 IU/L Accepted Accepted Anti-HBs < 200 IU/L Accepted Rejected
6 Development of screening strategies for HBV Serology 1972 HBsAg (agglutination method) 1989 Anti-HBc/anti-HBs Anti-HBc cutoff.. x years sample storage NAT 1997 Anti-HBc cutoff.. x p-NAT (HBV, HCV, HIV) p-NAT p-NAT 2008 ŐŐůƵƟŶĂƟŽŶї >/ p-NAT (sample vol. x3) 2012 Entire anti-hbc-positives rejected 2014 ID-NAT
7 Recent incidence of TT-HBV after introduction of entire exclusion of anti-hbc-positives 8 Cases/y WP-related OBI-related p-NAT 20p-NAT new Improved 20p 20p-NAT HBcAb Aug 2012 Total exclusion of anti-hbc-positives
8 HIV-1-positive blood donations in Japan Seronegative but NAT-positives ; 1.9 / y
9 May p-NAT-negative Source plasma Nov 2003 HIV-Ab-positive RBC FFP Repository sample Discarded Ab-positive, HIV-RNA-positive ID-NAT-positive Feb p-NAT-negative Nov 2013 HIV-Ab-positive RBC FFP Ab-negative, HIV-RNA-negative Ab-positive, HIV-RNA-positive Repository sample ID-NAT-positive (1 of 3 NAT system)
10 Blood needs of the aging population and JRC approach to donor recruitment
11 Composition of Japanese population y 15 million 100 y 29.5 million M F M F M F 27 million 20 million
12 Future prospect of blood donors in Japan Population eligible for blood donation million % decrease No. of donors needed Predicted no. of donors
13 For Securing a Stable Blood Supply 1. To promote the appropriate use of blood products (Law on Securing a Stable Supply of Safe Blood Products, 2003) It is obligatory for physicians to use blood appropriately 2. Incorporation of blood donation into the guideline of study in high school (2009) Insertion of the pictures of blood mobile and blood donation room in the textbook of health and physical education (2013) 3. To increase educational session on blood science, blood transfusion and blood donation at schools
14 No. of school visits and lessons Elementary school Jr. high school High school Technical school University Others No. of participants Elementary school Jr.high school High school University Technical school Others
15 Class of Blood, health and blood donation at elementary school Youth Seminar Blood Donation at university
16 For Securing a Stable Blood Supply 4. To increase the number of young donors Donors in teens ( % in 2020) Donors in twenties ( % in 2020) 5. To increase companies cooperating on blood donation (50,712 companies and organizations registered in 2013) Symbol mark given companies joining group blood donation
17 For Securing a Stable Blood Supply 6. To increase repeat donors up to 1,200,000 (996,684 at present) Establishment of Multiple blood donation club Registration of address through mobiles/ PCs Offering information and sending request for donation by e- mail 7. Blood donation promoting campaigns Give Blood at Twenty : January~ February Supporting each other with love : July Christmas Blood Donation Nationwide Students Campaign : December 300 volunteer organizations consisting of 5,000 students LOVE in Action PROJECT since 2012 targeting 10s and 20s
18
19 Incidence of post-transfusion hepatitis in Japan (%) % paid donors 31.1% paid & voluntary donors % voluntary donors 14.3 % HBs Ag testing 8.7 % 400mL collection 2.1 % HBcAb & HCV Ab 0.48 % HCV Ab 2 nd gen
20 Established TT-HBV cases in Japan 16 Cases pool NAT 20-pool NAT Improved 20-pool NAT
21 輸血による HCV 感染 献血者採血日検査結果 44 歳女性 2004/04/07 スクリーニンク 検査 (-) 保管検体個別 NAT copies/ml (1b) 21 歳女性 2003/11/07 スクリーニンク 検査 (-) 保管検体個別 NAT copies/ml (2a) 22 歳男性 2007/08/-- スクリーニンク 検査 (-) 保管検体個別 NAT copies/ml (2a) 30 歳代女性 2006/11/-- スクリーニンク 検査 (-) 保管検体個別 NAT 増幅不可 (2a) 2 例に感染 50 歳代女性 2009/06/-- スクリーニンク 検査 (-) 2013 年抗体陽転化にて遡及保管検体個別 NAT 陽性 (1b)
22 Bacterial infection caused by transfusion (SHOT in UK) Data in before cultural screening Components Bacteria Storage (Days) Patient outcome AP-PC AP-PC Klebsiella pneumoniae Group G Streptococcus 3 Fatal 4 Fatal 4 Serious, Recovered 5 Serious, Recovered Pooled PC Group G Streptococcus 4 Serious, Recovered AP-PC S. pneumoniae 5 Serious, Recovered 3 Serious, Recovered Pooled PC S. epidermidis 6 Serious, Recovered RBC Pseudomonas koreensis 19 Fatal
23 Suspected and established TT-sepsis RBC RBC PC PC PC Red ; established cases PC PC PC PC PC RBC PC JRC will keep PC shelf life short (3.5 days) Culture negative etc
24 Age distribution of blood donors and blood recipients (2012) % recipients donors Age
25 Number of blood donors by age group 250 X s 40s s '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 '13
26 LOVE in Action PROJECT since 2012 targeting 10s and 20s Musicians Students Volunteers Football Player Radio Program
27 Final Event - LOVE in Action Meeting(LIVE) Numbers of Love in Action were conducted from July 2012 to June 2013, and as a final event a live-music concert was held with great success.
28 For Securing a Stable Blood Supply 6. To increase repeat donors up to 1,200,000 (now 996,684) Establishment of Multiple blood donation club Registration of address through mobiles/ PCs Offering information and sending request for donation by 7. Blood donation promoting campaigns Give Blood at Twenty : January February Supporting each other with love : July Christmas Blood Donation Nationwide Students Campaign : December 300 volunteer organizations consisting of 5,000 students
2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies
2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies Submitted by: Malaysia Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply Chain Manila, Philippines 30 September 1
More informationImpact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013
Impact of Testing Strategies to Reduce Transmission Risk for HBV Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013 Overview of SANBS SANBS is a private not for profit company
More informationChapter 17: Transfusion-Transmitted Infections (TTI)
Annual SHOT Report 2014 Supplementary Information Chapter 17: Transfusion-Transmitted s (TTI) The table below is an excerpt from the full Table 17.2 which can be viewed in the main report. Case reports
More informationImpact of multi-dye multiplex technology on testing algorithm
Impact of multi-dye multiplex technology on testing algorithm Lydia Blanco. Mª Isabel Gonzalez-Fraile Centro de Hemoterapia y Hemodonación de Castilla y León, España TTI EPIDEMIOLOGICAL DATA IN SPAIN NAT
More informationHBV 感染既往の血液に対する更なる安全対策について
平成 23 年 9 月 28 日開催薬事 食品衛生審議会運営委員会提出資料 HBV 感染既往の血液に対する更なる安全対策について 日本赤十字社血液事業本部 1. 現在の HBV 関連検査 1)HBs 抗原 (CLEIA) 2) スクリーニング NAT(HBV HCV HIV)/ 20 本プール 3)HBc 抗体及び HBs 抗体 HBc 抗体の判定ロジック HBc 抗体 (COI) 1 以上 12
More informationAnnual SHOT Report 2016 Supplementary Information. Chapter 17: Transfusion-Transmitted Infections (TTI)
Annual SHOT Report 2016 Supplementary Information Chapter 17: Transfusion-Transmitted s (TTI) The table below is an excerpt from the full Table 17.3 which can be viewed in the main report. Case reports
More informationImpact of donor epidemiology and screening strategies on the safety of blood and plasma for fractionation
IPFA 2 nd Asia Workshop in Yogyakarta Impact of donor epidemiology and screening strategies on the safety of blood and plasma for fractionation Yoshihiko Tani, MD, PhD Japanese Red Cross Osaka Blood Center
More informationChallenges in HBV detec1on in blood donors
Challenges in HBV detec1on in blood donors Jean- Pierre Allain Dept Haematology, University of Cambridge, UK Phylogene1c analysis of human and ape HBV over 1me of evolu1on (Pareskevis et al, Hepatology
More informationNAT Screening of Blood Donations in NBC, TRCS
IPFA/PEI, Italy NAT Screening of Blood Donations in NBC, TRCS 2000-2001 Clinical evaluation using COBAS AmpliiScreen HIV & HCV assays, (MP24) window period rate - 1 : 108,768 for HIV-1 and HCV 2002 Routine
More informationAPPROACH TO RISK MANAGEMENT IN MEDICAL PRACTICE: STANDPOINT OF THE BLOOD TRASFUSION*
11 APPROACH TO RISK MANAGEMENT IN MEDICAL PRACTICE: STANDPOINT OF THE BLOOD TRASFUSION* Hisami IKEDA** Asian Med. J. 44(1): 11 21, 2000 Abstract: In the field of blood transfusion, risk management is defined
More informationProbability of false initial and repeat ID-NAT reactive donations. Marion Vermeulen IPFA Rome 2014
Probability of false initial and repeat ID-NAT reactive donations Marion Vermeulen IPFA Rome 2014 Overview of SANBS SANBS is a non profit organization Provides a vein to vein blood transfusion service
More informationFrequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India.
Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India. Cinzia Keechilot, Veena Shenoy 1,V Anil kumar 2,Lalita Biswas 3. MBBS student * Transfusion
More informationOverview of Blood Transfusion System of Iran:
Report Article Overview of Blood Transfusion System of Iran: 2002-2011 AM Cheraghali High Institute for Research and Education on Transfusion Medicine, Iran Blood Transfusion Organization and University
More informationTRANSFUSION ASSOCIATED DISEASE, RECALL, OR COMPLICATION INVESTIGATION POLICY I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION:
I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION: A. TRANSFUSION RELATED FATALITY: FDA and MEDIC must be notified immediately, and subsequently in writing, when a possible transfusion related
More informationBacterial Screening of Platelet Concentrates
Bacterial Screening of Platelet Concentrates Enda Cadden Platelet Donations Very Short shelf-life
More informationHUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE. Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, May, 2012.
HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, 23-24 May, 212. BLOOD DONATION G I V I N G I S G O O D ORGAN COORDINATION OFFICE
More informationrisk of Transfusion-Transmitted Transmitted Viral Infections (HIV, HCV and HBV)
Prevention and ResidualR risk of Transfusion-Transmitted Transmitted Viral Infections (HIV, HCV and HBV) Syria Laperche L (Centre National de référence r rence pour les hépatites h B et C en Transfusion)
More informationHEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS. Joana Bikulčienė Director of National blood center
HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS Joana Bikulčienė Director of National blood center j.bikulciene@kraujodonoryste.lt Organizational structure of Lithuanian blood service 1 specialized
More informationBLOOD SAFETY STATUS IN INDONESIA. Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine
BLOOD SAFETY STATUS IN INDONESIA Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine OUTLINE Background Blood services in Indonesia Regulation related to blood safety in Indonesia
More informationHepa%%s E Virus Is it a Concern?
IPFA/PEI 17 th Workshop on Surveillance and Screening of Blood Borne Pathogens 26-27 May 2010, The Regent Esplanade Zagreb Hotel, Zagreb, Croa%a Hepa%%s E Virus Is it a Concern? Keiji Matsubayashi Hokkaido
More informationScreening donors and donations for transfusion transmissible infectious agents. Alan Kitchen
Screening donors and donations for transfusion transmissible infectious agents Alan Kitchen Aim Not to teach you microbiology To provide and awareness of the big picture To provide an understanding of
More informationReport to UNAIDS HIV / AIDS Trends in Japan December 2009
Report to UNAIDS HIV / AIDS Trends in Japan December 2009 図 Number 5. HIV 感染者および of People LivingAIDS with患者の年次推移 HIV and AIDS 1200 人 1000 800 HIV AIDS 600 400 200 0 1985 1986 1987 1988 1989 1990 1991
More informationReporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey
Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey This questionnaire consists of three sections: A. Collection and
More informationAccuVert HBV Seroconversion Panel PHM941(M) ( )
PACKAGE INSERT PHM941(M) (0605-0061) INTENDED USE PHM941(M) (0605-0061) is a group of serial bleeds from an individual plasma donor during HBV seroconversion. This panel is intended for use by diagnostics
More information2014/LSIF/PD/030 Risk Assessment and Cost-Effectiveness of Blood Safety Interventions for HIV, HCV, and HBV Development of a Web-Based Application
2014/LSIF/PD/030 Risk Assessment and Cost-Effectiveness of Blood Safety Interventions for HIV, HCV, and HBV Development of a Web-Based Application Submitted by: Blood Systems Research Institute (BSRI)
More informationImpact of changing donor demographics on HIV transmission risk: A ten year analysis of individual donation NAT screening
Impact of changing donor demographics on HIV transmission risk: A ten year analysis of individual donation NAT screening IPFA Lisbon 216 Marion Vermeulen Disclaimer Race classifications are described as
More informationLaboratory reports of hepatitis A and C infection in England and Wales: January to March
Volume 4 29 Published on: 23 July 2010 Current News Increased diagnoses of HIV infection in the over-50s in UK Infection Reports Immunisation Laboratory reports of hepatitis A and C infection in England
More information2014/LSIF/PD/008 Building Blocks and Challenges to Implementing a National Blood Program in Malaysia
2014/LSIF/PD/008 Building Blocks and Challenges to Implementing a National Blood Program in Malaysia Submitted by: Malaysia Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply
More informationThe testing of Donated Blood and Components at NHSBT
The testing of Donated Blood and Components at NHSBT NHSBT is responsible for collecting all donated blood and platelets in England, then processing into components before issuing to client hospitals.
More informationUvA-DARE (Digital Academic Repository) Residual infectious risks in blood transfusion Lieshout-Krikke, R.W. Link to publication
UvA-DARE (Digital Academic Repository) Residual infectious risks in blood transfusion Lieshout-Krikke, R.W. Link to publication Citation for published version (APA): Lieshout-Krikke, R. W. (2016). Residual
More informationThe cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Jackson B R, Busch M P, Stramer S L, AuBuchon J P
The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Jackson B R, Busch M P, Stramer S L, AuBuchon J P Record Status This is a critical abstract of an economic evaluation that meets
More informationAccuSet HBV Worldwide Performance Panel
PACKAGE INSERT 0805-033 INTENDED USE The is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot HBV test methods. Characterized samples
More informationLookback studies to assess viral risks The French experience
Lookback studies to assess viral risks The French experience 2000-2012 S Laperche 1, MF Leconte des Floris 2, J Pillonel 3, L Hauser 2, C Lefort 2, JY Py 2, I Hervé 2, R Djoudi 2 For the French haemovigilance
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationUpdate on AIDS in China
Update on AIDS in China Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA March, 2013 1 HIV epidemic in Asia General Population Family Bridge Population
More informationThe Alphabet Soup of Viral Hepatitis Testing
The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,
More informationProposed 1 st IS for Hepatitis E Virus RNA WHO/BS/
www.pei.de Proposed 1 st IS for Hepatitis E Virus RNA WHO/BS/09.2126 S. Baylis, Division of Virology, Paul-Ehrlich-Institut, Langen, Germany SoGAT XXII 14 th -15 th April 2011, Rome, Italy Presented at:
More informationPathogen Reduction/Inactivation KABB Annual Meeting Elpidio Pena, MD, MA Norton Healthcare Transfusion Services
Pathogen Reduction/Inactivation KABB Annual Meeting 2017 Elpidio Pena, MD, MA Norton Healthcare Transfusion Services Goals Discuss the approved methods for pathogen reduction/inactivation of blood products
More informationRAPID BACTERIAL DETECTION METHODS FOR PLATELETS. M. Schmidt
RAPID BACTERIAL DETECTION METHODS FOR PLATELETS M. Schmidt Deutsches Rotes Kreuz Blutspendedienst Baden-Württemberg-Hessen Goethe Universität Frankfurt am Main Institut für Transfusionsmedizin und Immunhämatologie
More informationInfectious Disease Considerations in Organ Donation. Nikole A Neidlinger MD FACS Chief Medical Officer
Infectious Disease Considerations in Organ Donation Nikole A Neidlinger MD FACS Chief Medical Officer Screening Donors and Infectious Disease considerations: Deceased Donor Screening Donors at increased
More informationThe establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas
Blood Safety Global Database on Blood Safety (GDBS) 2013 The World Health Organization (WHO) programme on Blood Transfusion Safety would appreciate your kind cooperation in completing this data collection
More informationTransfusion transmitted infections in National Haemovigilance Systems: the Greek experience
Transfusion transmitted infections in National Haemovigilance Systems: the Greek experience Global blood product safety 10 April 2019, Rome, Italy Constantina Politis National Coordinating Haemovigilance
More informationDONOR RECRUITMENT AND PLASMA COLLECTION IN INDONESIA. Yuyun SM Soedarmono Blood Services Committee Ministry of Health of Indonesia 1
DONOR RECRUITMENT AND PLASMA COLLECTION IN INDONESIA Yuyun SM Soedarmono Blood Services Committee Ministry of Health of Indonesia 1 OUTLINE Introduction Challenges to Fulfill Global Demand of Plasma for
More informationInfected: Bloodlines By Andrea Speed READ ONLINE
Infected: Bloodlines By Andrea Speed READ ONLINE WebMD describes the anatomy of human blood including what makes up our blood and how circulation works. Septicemia is a serious bloodstream infection. It
More informationSince 1973 all blood donations in the Netherlands
ORIGINAL RESEARCH Rare transmission of hepatitis B virus by Dutch donors with occult infection Ryanne W. Lieshout-Krikke, 1 Marian G.J. van Kraaij, 2 Fikreta Danovic, 2 and Hans L. Zaaijer 1 BACKGROUND:
More informationBACTERIAL INTERVENTIONS TO INCREASE BLOOD SAFETY
BACTERIAL INTERVENTIONS TO INCREASE BLOOD SAFETY Jennifer Allen National Bacteriology Laboratory on behalf of Dr. C P McDonald Head of Bacteriology National Bacteriology Laboratory NHSBT Klebsiella oxytoca
More informationHIV-1 AccuVert Seroconversion Panel (PRB966) / Batch #
s/co c/ml DATA SHEET OVERVIEW 0600-0248 (PRB966) is a 10-member panel of undiluted, naturally occurring plasma samples. Panel members represent serial bleeds collected from a single patient over the course
More informationseroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north india
Indian J Med Res 142, September 2015, pp 317-322 DOI:1103/0971-5916.166598 seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north india R.N. Makroo,
More informationGuidance for Industry
Guidance for Industry Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately
More informationConfirmed (Laboratory Tests) Serum positive for IgM anti-hbc or, hepatitis B surface antigen (HbsAg).
Hepatitis B Hepatitis B is a liver disease that results from infection with the Hepatitis B virus. It can range in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis
More informationThe Counselling of Blood Donors Identified as HIV Reactive. A Review as from January 2007 until June 2011
The Counselling of Blood Donors Identified as HIV Reactive A Review as from January 2007 until June 2011 The Blood Transfusion Service of Namibia Dr. Regine Redecker Mr. Tinus Matyayi 2 3 Background -TTI
More informationBlood Supply and Wastage
Blood Supply and Wastage Inga Willett Lab Matters, Oake Manor, 21 st June 2017 Blood supply UK supplied by 4 blood services: SNBTS NIBTS NHSBT WBS http://commons.wikimedia.org/wiki/file:uk_map_home_nations.png
More informationKeeping the Blood Supply Safe Current and Future Strategies. Marissa Li, MD
Keeping the Blood Supply Safe Current and Future Strategies Marissa Li, MD Overview Pre-collection Donor Screening Collection Visual Inspection Aseptic Processing Leukoreduction of Apheresis Collections
More informationLab Underwriting Puzzler. Presented by: Bill Rooney, M.D.
Lab Underwriting Puzzler Presented by: Bill Rooney, M.D. Obtaining Best Results from this presentation For best results please do the following: Select Slide Show from the menu option on top Select From
More informationPlasma for fractionation: South African Plasma Requirements
Plasma for fractionation: South African Plasma Requirements Dr Jeh-han Omarjee Head: Microbiological Sciences NBI is a "not for profit" company committed to providing safe, cost effective, quality medicinal
More informationEvaluation of external NAT controls from two manufacturers
Evaluation of external NAT controls from two manufacturers Aneta Kopacz, Institute of Hematology and Transfusion Medicine, Warsaw, Poland NAT and External QC in Poland (2018) SCREENING Regional Blood Transfusion
More informationQSEAL Recovered Plasma Specification
QSEAL Recovered Plasma Specification Background The is part of a series of standards that comprise the Plasma Protein Therapeutics Association (PPTA) QSEAL Standards Program. PPTA's Voluntary Standards
More informationHaemovigilance by JRCS
Haemovigilance by JRCS 04 Safety Vigilance Division Blood Service Headquarters Table of Contents Haemovigilance system of Japanese Red Cross Society. Reports on adverse reactions and TTIs ) Transfusion-related
More information感染性腹部大動脈瘤の診断における PET-CT 検査の有用性について
Online publication December 27, 2011 総 説 第 51 回総会シンポジウム 5 各種脈管画像診断の進歩と将来展望 感染性腹部大動脈瘤の診断における PET-CT 検査の有用性について 1 1 1 1 1 2 1 要旨 : CT 2007 6 2010 5 97 6 PET-CT CT PET-CT 6 4 2 SUVmax 5.0 FDP SUVmax 3.0 2
More informationGuidance for Industry
Guidance for Industry Advisement for the Use of Gen-Probe Procleix Ultrio Plus Assay for NAT Testing on Cadaveric Donors Release Date: 08/03/14 American Medical Education and Research Association 4757
More informationHEPATITIS B MANAGEMENT
HEPATITIS B MANAGEMENT Background Chronic Hepatitis B Virus (HBV) infection had an estimated prevalence in Australia of 0.7-0.8% in 2002 (1). Prevalence is highest in people born in much of Asia and Africa
More informationArmed Services Blood Program
Armed Services Blood Program Defense Health Board Concerns Regarding the Collection and Transfusion of Non-FDA Compliant Blood Products in Theater Information Brief Defense Health Board 17 August 2009
More informationNon-reproductive tissues and cells
Ministry of Health: Institute for Transplantation and Biomedicine / Colour key VIRAL HIV 1 and HIV 2 Hepatitis B Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More
More informationSURGICAL TREATMENT OF PULMONARY MYCOBACTERIOSIS FOR THE PAST 10 YEARS
Surgical Treatment of Mycobacteriosis /T.Hashizume et al. 437 Current Topics SURGICAL TREATMENT OF PULMONARY MYCOBACTERIOSIS FOR THE PAST 0 YEARS Toshinori HASHIZUME, 2 Kenji HAYASHIBARA, 2 Takefumi SAITO,
More informationAge and High-dose Oral Glucocorticoid Therapy Increase the Relative Risk of Cytomegalovirus Antigenemia in Patients with Systemic Autoimune Diseases
E-mail: CMV infection have ben established 4)-7). CMV infection 16 Original ljtok 川山 eduniv1 85 (6) 0~07 (015) Age and High-dose Oral Glucocorticoid Therapy Increase the Relative Risk of Cytomegalovirus
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT. APPENDICES a TO GUIDELINE ON EPIDEMIOLOGICAL DATA ON BLOOD TRANSMISSIBLE INFECTIONS
European Medicines Agency Evaluation of Medicines for Human Use London, 20 May 2009 Doc. Ref. EMEA/CPMP/BWP/125/04 Rev.1 Appendices COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT APPENDICES
More informationDiagnostic Methods of HBV and HDV infections
Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection
More informationAnti-HBc: state of the art what is the CORE of the issues?
Anti-HBc: state of the art what is the CORE of the issues? Robert G Gish MD Adjunct Professor Stanford University Medical Director Hepatitis B Foundation Disclosures: See robertgish.com If you wish an
More informationGuide to the preparation, use and quality assurance of blood components
Contents Foreword...3 Members of the European Committee (Partial Agreement) on Blood Transfusion... 8 Members of the GTS working group... 22 Members of the TS066 working group... 30 Recommendation No.
More informationtransfusion-transmissible HCV and HIV in Italy Haemovigilance and the residual risk of
Haemovigilance and the residual risk of transfusion-transmissible Giuliano Grazzini, MD National Blood Centre, National Institute of Health, Rome, Italy & International Federation of Blood Donor Organizations
More informationExperiences with frozen blood products in the Afghan theater (Aug 2006 Aug 2008)
Experiences with frozen blood products in the Afghan theater (Aug 2006 Aug 2008) CCM Lelkens, SBB(ASCP) Cdr (MC) (Royal Netherlands Navy) CO NLD Military Blood Bank 1 Outline Introduction ISAF / OEF facts
More informationImplementation: To be determined by each Service. Change Notification UK National Blood Services No
Date of publication: 30 th October 2017 Implementation: To be determined by each Service Change Notification UK National Blood Services No. 33-2017 This change applies to the Whole Blood and Components
More informationInspections, Compliance, Enforcement, and Criminal Investigations. Central Texas Regional Blood & Tissue Center 07-Nov-03
1 of 7 6/10/2009 2:20 PM Inspections, Compliance, Enforcement, and Criminal Investigations Department of Health and Human Services Public Health Service Food and Drug Administration Dallas District 4040
More informationAccuSet Anti-HIV-1 Mixed Titer Performance Panel
signal to cut-off (s/co) DATA SHEET OVERVIEW PRB205(M3) is a modified 16-member panel originating from Anti- HIV-1 Mixed Titer PRB205(M2). Panel members 3, 5, 6, 17, 21, 22, 23, 24, and 25 from the original
More informationTsung-Ming Chen, Sheng-Nan Lu, Jing-Houng Wang, Hung-Da Tung, Pei-Lun Lee, and Chuan-Mo Le
The Prevalence and Its Meaning of Anti-HBc Alone 15 Years Subsequent to Mass Hepatitis B Vaccination Tsung-Ming Chen, Sheng-Nan Lu, Jing-Houng Wang, Hung-Da Tung, Pei-Lun Lee, and Chuan-Mo Le Division
More informationFrench National Experience. EFS Medical Director
HEMOVIGILANCE French National Experience Dr Rachid DJOUDI EFS Medical Director Tehran - December 2015 Hemovigilance in France In France, hemovigilance was defined by law since 1993 (last modified by article
More informationIl ruolo delle VEQ per la sicurezza trasfusionale
Il ruolo delle VEQ per la sicurezza trasfusionale The role of EQA for transfusion safety Giulio Pisani CNCF Ist. Sup. Sanità Global Blood Product Safety, Roma 10 aprile 2019 Blood transfusion is an essential
More informationHaemovigilance by JRCS
Haemovigilance by JRCS 203 Safety Vigilance Division Blood Service Headquarters Table of Contents Haemovigilance system of Japanese Red Cross Society.... Reports on adverse reactions and TTIs... 2 ) Transfusion-related
More informationNational Screening laboratory Sanquin The use of NAT in blood donation screening in The Netherlands. TransMed conference Bhopal 18 November 2016
Dr. Anton van Weert National Screening laboratory Sanquin The use of NAT in blood donation screening in The Netherlands TransMed conference Bhopal 18 Introduction Thank you! Anton van Weert, PhD, MBA Manager
More informationConversion of Whole Blood Donors to Plasma Pheresis Donors
Conversion of Whole Blood Donors to Plasma Pheresis Donors IPFA 2 nd Asia Workshop on Plasma Quality and Supply Jonathan A. Hughes, M.D. Medical Director BloodSource, USA About BloodSource California,
More informationIn October 2005, the South African National Blood
DONOR INFECTIOUS DISEASE TESTING Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk_3355
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091606 Age 24 Years Gender Male 30/8/2017 92800AM 30/8/2017 94631AM 31/8/2017 90306AM Ref By Final HEATITIS A & B VIRUS EVALUATION HEATITIS A ANTIBODY (ANTI HAV),
More information頸動脈の超音波検査 頸動脈エコーの原理 患者情報の収集 検査時の患者の体位 超音波装置の条件設定 特集 : 脈管疾患診断における非侵襲的画像診断 : 進歩と現状. J Jpn Coll Angiol :
Online publication January 22, 2010 総 説 特集 : 脈管疾患診断における非侵襲的画像診断 : 進歩と現状 頸動脈の超音波検査 要旨 : J Jpn Coll Angiol 2009 49: 453 458 Key words: brain infarction, transient ischemic attack, amaurosis fugax, intima
More informationEC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK
National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on
More informationPublic Health, Infections and Transplantation
Public Health, Infections and Transplantation Dr Kerry Chant Chief Health Officer & Deputy Director General Population and Public Health NSW Ministry of Health May2014 Public Health Infection and Transplantation
More informationI. Yearly Trends in Youths Physical Fitness and Motor Skills ( )
6 Survey Result Details This survey has been conducted every year since 1964 and the 2013 survey marked its 50th anniversary. Such a survey, continuously measuring Japanese citizens physical fitness and
More informationHEV Assay Development Update
HEV Assay Development Update Jeffrey M. Linnen, Ph.D. Senior Director, Research & Development Hologic Gen-Probe, San Diego, California USA IPFA/PEI 20th International Workshop on Surveillance and Screening
More informationHepatitis B. ECHO November 29, Joseph Ahn, MD, MS Associate Professor of Medicine Director of Hepatology Oregon Health & Science University
Hepatitis B ECHO November 29, 2017 Joseph Ahn, MD, MS Associate Professor of Medicine Director of Hepatology Oregon Health & Science University Disclosures Advisory board Gilead Comments The speaker Joseph
More informationThe TTSN - A Collaborative Biovigilance System
The TTSN - A Collaborative Biovigilance System 5th World Congress on Tissue Banking 12th International Conference of the APASTB Kuala Lumpur, Malaysia June 4, 2008 Scott A. Brubaker, CTBS American Association
More informationPLATELETPHERESIS DONOR REGISTRY FOR INDIA. Prashant Pandey Jaypee Hospital, Noida
PLATELETPHERESIS DONOR REGISTRY FOR INDIA Prashant Pandey Jaypee Hospital, Noida SDPC vs. RDPC INDEX Why plateletpheresis(pp) donor registry required in India Global and Indian perspective Jaypee hospital
More informationActive surveillance in young prostate cancer patients : From the PRIAS-JAPAN study
MP-7-2029 Active surveillance in young prostate cancer patients : From the PRIAS-JAPAN study Takuma Kato, Mikio Sugimoto, Yoshiyuki Kakehi, PRIAS-JAPAN Study Group Department of Urology, Kagawa University
More informationPlaying Detective: going in search of the source of infection. Su Brailsford Consultant in Epidemiology and Health Protection
Playing Detective: going in search of the source of infection Su Brailsford Consultant in Epidemiology and Health Protection The Micro Services clinical team Are inquisitive Like problem solving Don t
More informationMultiple Chemical Sensitivity(MCS) due to passive smoking: A unique Japanese syndrome?
Multiple Chemical Sensitivity(MCS) due to passive smoking: A unique Japanese syndrome? Michiyuki Matsuzaki,MD Internal Medicine, Fukagawa City Hospital, Hokkaido, Japan matsuzak@maple.ocn.ne.jp Multiple
More informationInfectivity of HBV DNA positive donations identified in look-back studies in Hyogo-Prefecture, Japan
Transfusion Medicine, 2011, 21, 107 115 doi: 10.1111/j.1365-3148.2010.01057.x ORIGINAL ARTICLE Infectivity of HBV DNA positive donations identified in look-back studies in Hyogo-Prefecture, Japan Y. Bouike,
More informationSituation of XMRV and Blood Transfusion. Celso Bianco, MD ISBT Working Party on TTID Lisbon, June 19, 2011
Situation of XMRV and Blood Transfusion Celso Bianco, MD ISBT Working Party on TTID Lisbon, June 19, 2011 Lombardi et al. Science 326, 585 (2009) Conclusions: CFS and XMRV XMRV found in 67% of CFS patients
More informationOriginal article J Bas Res Med Sci 2017; 4(2):4-8.
Prevalence of HIV, hepatitis B and C infections among volunteer blood donors at the blood transfusion center of Ilam city, Iran Hasan Boustani 1, Enayat Anvari 2, Sedighe Saiadi Sartang 2, Mehdi Omidi
More informationHBV-DNA reference panels
HBV-DNA reference panels The kit insert contains a detailed protocol and should be read carefully before testing the run control to ensure optimal performance Table of contents Overview HBV-DNA panels
More informationDEVELOPMENT OF AN INTERNATIONAL REFERENCE PREPARATION FOR HEPATITIS D VIRUS RNA - UPDATE
DEVELOPMENT OF AN INTERNATIONAL REFERENCE PREPARATION FOR HEPATITIS D VIRUS RNA - UPDATE SoGAT Clinical Diagnostics III 12-13 January 2011, London Michael Chudy Julia Kreß Micha Nübling Paul-Ehrlich-Institut
More informationESCCMID OLL. by Author. Hepatitis in immunocompromised hosts. Treviso, July 5, Saverio G Parisi
Hepatitis in immunocompromised hosts Treviso, July 5, 2011 Saverio G Parisi Department of Histology, Microbiology and Medical Biotechnology Università di Padova HBV Virological categories Persistent HBV
More information